Dr. Ajay Kirtane and Dr. Yazan Daaboul: RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration November 4, 2021 Disclosures: TBA
Dr. Haibo Jia, Jingbo Hou, and Dr. C. Michael Gibson Discuss: EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency November 4, 2021 Disclosures: TBA
Dr. Bo Xu and Dr. C. Michael Gibson Discuss: FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI November 4, 2021 Disclosures: TBA
Dr. William Fearon and Dr. C. Michael Gibson Discuss: FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG November 4, 2021 Disclosures: TBA
Dr. David E. Kandzari and Dr. C. Michael Gibson Discuss: OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG November 4, 2021 Disclosures: TBA
Dr. Robert Yeh, Dr. Ajay Kirtane, and Dr. C. Michael Gibson Discuss: ESC 2021 Wrap-Up: MASTER-DAPT & STOPDAPT2-ACS August 30, 2021 Disclosures: TBA
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss the Updates to the ESC CHF Guidelines and How to Initiate Medications to Optimize Outcomes August 30, 2021 Disclosures: TBA
Dr. Hirotoshi Watanabe and Dr. C. Michael Gibson Discuss: STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome August 30, 2021 Disclosures: TBD
